HB 1199 mandates that health insurance plans cover genetic testing and treatments for SCN2A-associated medical conditions without imposing cost-sharing fees on members who are covered under their policy. The bill requires insurers to include these specific services in their coverage without charging patients a portion of the cost. This legislation directly affects individuals with SCN2A-related conditions and the health insurance providers who must adjust their benefit structures accordingly.
HB 1160 amends the laws governing rural physician licenses by updating specific terminology and clarifying the requirements for obtaining such licenses. The bill modifies the definition of a medical degree and adds language to ensure that licensing determinations are both approved and adopted through established administrative processes. It also changes the conditions under which a physician can be licensed, requiring them to meet a specific set of criteria rather than a single provision. These changes directly affect doctors practicing in rural areas and the state agencies responsible for issuing their medical licenses.
This bill, titled the Louisiana Clinical Trial Competitiveness and Patient Access Act, aims to support economic development by establishing a framework for clinical trials within the state. It directly affects healthcare providers, pharmaceutical companies, and patients by creating new provisions to enhance the competitiveness of clinical research in Louisiana. The legislation includes specific amendments that clarify the law does not override federal restrictions and expands the scope of protected protocols to include nonpublic ones. By adding these details, the bill seeks to provide clearer guidelines for conducting clinical trials while ensuring compliance with existing federal regulations.
This bill amends Louisiana law to require the Medicaid program to cover continuous glucose monitors for pregnant women with diabetes who use insulin more than twice daily or have experienced severe low blood sugar. The change specifically includes gestational diabetes, ensuring that eligible expectant mothers receive access to these monitoring devices as part of their treatment plan. By updating the state's Medicaid statutes, the legislation directly affects pregnant enrollees and the healthcare providers who administer their care.
This bill requires healthcare facilities in Louisiana to provide specific behavioral health services to patients admitted under emergency certificates. Upon admission, facilities must conduct a behavioral health evaluation within 72 hours and contact the patient's primary healthcare provider to review treatment history. At discharge, staff must notify healthcare professionals about the patient's release, provide a medical summary to follow-up providers, distribute educational materials about warning signs and privacy rights, and ensure patients receive at least a 14-day medication supply. The law also mandates that the Louisiana Department of Health create and publish these educational documents for patients and their families.
This bill requires insurance contracts in Louisiana to include a minimum prescriptive period of 24 months for first-party claims and one year for other claims, preventing insurers from limiting the time policyholders have to file lawsuits. It also clarifies that making a payment under an insurance contract does not reset or extend the deadline for filing a claim. The law applies to insurance policies covering residents or property located in Louisiana, including health and accident policies for state residents.
HB 944 creates the Louisiana Women's Health Consortium within the Louisiana Department of Health to address women's health needs across the state. The consortium will include 15 voting members representing health institutions (like Tulane School of Medicine and Woman's Hospital), government agencies (such as the surgeon general's office), and community stakeholders, plus nonvoting members from additional health organizations. Its core duties include developing a state funding plan for women's health initiatives, creating a comprehensive Women's Health Agenda focusing on issues like perimenopause and menopause, and identifying systemic barriers to care. The consortium must hold quarterly public meetings, submit an annual report to the legislature, and coordinate an online resource hub for evidence-based women's health information.
HB 302 prohibits new permits for businesses to sell vapor products within 300 feet of school property lines. It directly affects businesses seeking to open or operate vapor product sales near schools, requiring them to be at least 300 feet away. The bill specifies measurement can be either by sidewalk path (in areas with sidewalks) or straight line, with the straight-line method applying only to new permits issued after its adoption. This policy change restricts where new vapor product businesses can operate near schools but does not affect existing businesses.
This bill removes the legal provision that set a termination date for the Louisiana Behavior Analyst Board, allowing the regulatory body to continue operating. By repealing the specific statute that established the board's expiration, the legislation ensures the board remains active for overseeing behavior analysts in the state. The change directly affects the board's ability to regulate professionals and maintain oversight without a fixed end date. No new powers or requirements are added; the bill simply eliminates the existing deadline for the board's existence.
This bill requires health insurance companies in Louisiana to cover mobile crisis response and behavioral health crisis care services when provided by eligible licensed providers. The law mandates that these services do not need prior authorization from insurers and allows providers to coordinate with the state's Crisis Hub for information sharing. Coverage may include standard cost-sharing options like deductibles and copayments, while reimbursement methods remain up to each insurer's discretion. The bill defines these services as short-term, recovery-focused interventions for adults and children experiencing mental health or substance use crises, with an effective date of July 1, 2027.
